The global Medical Radioactive Microspheres market is projected to grow from US$ 195 million in 2024 to US$ 403 million by 2031, at a CAGR of 11.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Medical Radioactive Microspheres Market

Medical radioactive microspheres are a type of radioactive embolic agent that uses interventional means to inject micron-sized particles (usually 20-45 microns in diameter) containing radionuclides (such as yttrium [90Y]) into the tumor's blood supply artery. The carrier material is mostly ceramic, resin or glass. It releases beta rays through targeted tumors (to kill tumor cells at close range, and at the same time has the function of embolizing blood vessels, which can significantly improve the local control rate of tumors and reduce normal tissue damage. It is mainly used clinically for the treatment of solid tumors such as primary liver cancer and colorectal cancer liver metastasis that cannot be surgically removed. It has the advantages of high targeting, few side effects, and reliable efficacy, and can meet individualized treatment needs through customized personalized activity.

Future development trends, driving factors and obstacles of medical radioactive microspheres

Application field expansion

At present, medical radioactive microspheres are mainly used for liver cancer treatment, but in the future they are expected to be expanded to the treatment of other malignant tumors such as pancreatic cancer, bladder cancer, head and neck cancer, etc. In addition, with the advancement of technology, radioactive microspheres may play a greater role in the treatment of benign diseases.

Technological innovation and product upgrade

The preparation technology of radioactive microspheres will continue to be optimized, such as developing microspheres with smaller particle size and more uniform distribution to improve the treatment effect and reduce side effects. At the same time, the research on visual microspheres will promote the development of real-time monitoring technology, enabling doctors to control the distribution and dosage of microspheres more accurately.

Intensified market competition

As market demand grows, more and more companies will enter the field of medical radioactive microspheres, and market competition will become more intense. At present, major global manufacturers include Sirtex Medical and Boston Scientific Corporation, and more new players may emerge in the future.

Development drivers

Increasing cancer incidenc

The global cancer incidence rate is increasing year by year, especially malignant tumors such as liver cancer. According to the World Health Organization, liver cancer is the sixth most common cancer in the world and the third leading cause of cancer death. As an effective local treatment method, the market demand for radioactive microspheres will continue to grow.

Technological progress

The preparation technology and application technology of radioactive microspheres are constantly improving. For example, the research and application of yttrium [90Y] microspheres make treatment more accurate and safe. In addition, the research on visualized microspheres will further improve the controllability and effect of treatment.

Policy support

Governments of various countries have continuously increased their support for medical technology, especially in the field of cancer treatment. For example, China has introduced a series of policies to support the development of biopharmaceuticals and traditional Chinese medicine industries, and promote the industrialization of technologies such as sustained-release preparations and targeted preparations.

Development obstacles

Technical barriers

The preparation technology of medical radioactive microspheres is complex and requires high-precision equipment and processes. At present, domestic companies still have a certain gap in microsphere preparation technology, relying on imported materials and equipment, which increases production costs and supply chain uncertainty.

Market competition and price pressure

With the intensification of market competition, price pressure will increase. How to reduce production costs and improve market competitiveness while ensuring product quality and efficacy is a challenge faced by companies.

Regulation and approval

As medical devices, medical radioactive microspheres need to undergo strict supervision and approval. Different regulatory requirements in different countries and regions increase the difficulty and time cost of bringing products to market.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Medical Radioactive Microspheres market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Medical Radioactive Microspheres Market Report

Report Metric	Details
Report Name	Medical Radioactive Microspheres Market
Accounted market size in 2024	US$ 195 in million
Forecasted market size in 2031	US$ 403 million
CAGR	11.2%
Base Year	2024
Forecasted years	2025 - 2031
Segment by Type	Holmium-166 Microspheres Yttrium-90 Microspheres
Segment by Application	Cancer Treatment Diagnosis Others
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, Terumo, ABK Biomedical, AtomVie, BWXT Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Medical Radioactive Microspheres study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Medical Radioactive Microspheres Market growing?

Ans: The Medical Radioactive Microspheres Market witnessing a CAGR of 11.2% during the forecast period 2025-2031.

What is the Medical Radioactive Microspheres Market size in 2031?

Ans: The Medical Radioactive Microspheres Market size in 2031 will be US$ 403 million.

Who are the main players in the Medical Radioactive Microspheres Market report?

Ans: The main players in the Medical Radioactive Microspheres Market are New Radiomedicine Technology, Grand Pharmaceutical Group Limited, YH Nu-Med, Boston Scientific, Sirtex Medical Limited, Terumo, ABK Biomedical, AtomVie, BWXT Medical

What are the Application segmentation covered in the Medical Radioactive Microspheres Market report?

Ans: The Applications covered in the Medical Radioactive Microspheres Market report are Cancer Treatment, Diagnosis, Others

What are the Type segmentation covered in the Medical Radioactive Microspheres Market report?

Ans: The Types covered in the Medical Radioactive Microspheres Market report are Holmium-166 Microspheres, Yttrium-90 Microspheres

1 Study Coverage

1.1 Introduction to Medical Radioactive Microspheres: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Medical Radioactive Microspheres Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Holmium-166 Microspheres

1.2.3 Yttrium-90 Microspheres

1.3 Market Segmentation by Application

1.3.1 Global Medical Radioactive Microspheres Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 Cancer Treatment

1.3.3 Diagnosis

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Medical Radioactive Microspheres Revenue Estimates and Forecasts 2020-2031

2.2 Global Medical Radioactive Microspheres Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Medical Radioactive Microspheres Sales Estimates and Forecasts 2020-2031

2.4 Global Medical Radioactive Microspheres Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Medical Radioactive Microspheres Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Medical Radioactive Microspheres Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Holmium-166 Microspheres Market Size by Manufacturers

3.5.2 Yttrium-90 Microspheres Market Size by Manufacturers

3.6 Global Medical Radioactive Microspheres Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Medical Radioactive Microspheres Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Medical Radioactive Microspheres Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Medical Radioactive Microspheres Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Medical Radioactive Microspheres Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Medical Radioactive Microspheres Sales and Revenue by Type (2020-2031)

6.4 North America Medical Radioactive Microspheres Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Medical Radioactive Microspheres Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Medical Radioactive Microspheres Sales and Revenue by Type (2020-2031)

7.4 Europe Medical Radioactive Microspheres Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Medical Radioactive Microspheres Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Medical Radioactive Microspheres Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Medical Radioactive Microspheres Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Medical Radioactive Microspheres Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Medical Radioactive Microspheres Sales and Revenue by Type (2020-2031)

9.4 Central and South America Medical Radioactive Microspheres Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Medical Radioactive Microspheres Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Medical Radioactive Microspheres Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Medical Radioactive Microspheres Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Medical Radioactive Microspheres Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 New Radiomedicine Technology

11.1.1 New Radiomedicine Technology Corporation Information

11.1.2 New Radiomedicine Technology Business Overview

11.1.3 New Radiomedicine Technology Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.1.4 New Radiomedicine Technology Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 New Radiomedicine Technology Medical Radioactive Microspheres Sales by Product in 2024

11.1.6 New Radiomedicine Technology Medical Radioactive Microspheres Sales by Application in 2024

11.1.7 New Radiomedicine Technology Medical Radioactive Microspheres Sales by Geographic Area in 2024

11.1.8 New Radiomedicine Technology Medical Radioactive Microspheres SWOT Analysis

11.1.9 New Radiomedicine Technology Recent Developments

11.2 Grand Pharmaceutical Group Limited

11.2.1 Grand Pharmaceutical Group Limited Corporation Information

11.2.2 Grand Pharmaceutical Group Limited Business Overview

11.2.3 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.2.4 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales by Product in 2024

11.2.6 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales by Application in 2024

11.2.7 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres Sales by Geographic Area in 2024

11.2.8 Grand Pharmaceutical Group Limited Medical Radioactive Microspheres SWOT Analysis

11.2.9 Grand Pharmaceutical Group Limited Recent Developments

11.3 YH Nu-Med

11.3.1 YH Nu-Med Corporation Information

11.3.2 YH Nu-Med Business Overview

11.3.3 YH Nu-Med Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.3.4 YH Nu-Med Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 YH Nu-Med Medical Radioactive Microspheres Sales by Product in 2024

11.3.6 YH Nu-Med Medical Radioactive Microspheres Sales by Application in 2024

11.3.7 YH Nu-Med Medical Radioactive Microspheres Sales by Geographic Area in 2024

11.3.8 YH Nu-Med Medical Radioactive Microspheres SWOT Analysis

11.3.9 YH Nu-Med Recent Developments

11.4 Boston Scientific

11.4.1 Boston Scientific Corporation Information

11.4.2 Boston Scientific Business Overview

11.4.3 Boston Scientific Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.4.4 Boston Scientific Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Boston Scientific Medical Radioactive Microspheres Sales by Product in 2024

11.4.6 Boston Scientific Medical Radioactive Microspheres Sales by Application in 2024

11.4.7 Boston Scientific Medical Radioactive Microspheres Sales by Geographic Area in 2024

11.4.8 Boston Scientific Medical Radioactive Microspheres SWOT Analysis

11.4.9 Boston Scientific Recent Developments

11.5 Sirtex Medical Limited

11.5.1 Sirtex Medical Limited Corporation Information

11.5.2 Sirtex Medical Limited Business Overview

11.5.3 Sirtex Medical Limited Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.5.4 Sirtex Medical Limited Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Sirtex Medical Limited Medical Radioactive Microspheres Sales by Product in 2024

11.5.6 Sirtex Medical Limited Medical Radioactive Microspheres Sales by Application in 2024

11.5.7 Sirtex Medical Limited Medical Radioactive Microspheres Sales by Geographic Area in 2024

11.5.8 Sirtex Medical Limited Medical Radioactive Microspheres SWOT Analysis

11.5.9 Sirtex Medical Limited Recent Developments

11.6 Terumo

11.6.1 Terumo Corporation Information

11.6.2 Terumo Business Overview

11.6.3 Terumo Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.6.4 Terumo Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Terumo Recent Developments

11.7 ABK Biomedical

11.7.1 ABK Biomedical Corporation Information

11.7.2 ABK Biomedical Business Overview

11.7.3 ABK Biomedical Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.7.4 ABK Biomedical Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 ABK Biomedical Recent Developments

11.8 AtomVie

11.8.1 AtomVie Corporation Information

11.8.2 AtomVie Business Overview

11.8.3 AtomVie Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.8.4 AtomVie Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 AtomVie Recent Developments

11.9 BWXT Medical

11.9.1 BWXT Medical Corporation Information

11.9.2 BWXT Medical Business Overview

11.9.3 BWXT Medical Medical Radioactive Microspheres Product Models, Descriptions and Specifications

11.9.4 BWXT Medical Medical Radioactive Microspheres Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 BWXT Medical Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Medical Radioactive Microspheres Industry Chain

12.2 Medical Radioactive Microspheres Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Medical Radioactive Microspheres Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Medical Radioactive Microspheres Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Medical Radioactive Microspheres Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Medical Radioactive Microspheres Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

FEATURED COMPANIES

New Radiomedicine Technology

Grand Pharmaceutical Group Limited

YH Nu-Med

Boston Scientific

Sirtex Medical Limited

List of Tables

Table 1. Global Medical Radioactive Microspheres Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Medical Radioactive Microspheres Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Medical Radioactive Microspheres Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Medical Radioactive Microspheres Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Medical Radioactive Microspheres Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)

Table 7. Global Medical Radioactive Microspheres Sales by Region (2020-2025) & (K Dose)

Table 8. Global Medical Radioactive Microspheres Sales by Region (2026-2031) & (K Dose)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Medical Radioactive Microspheres Sales by Manufacturers (2020-2025) & (K Dose)

Table 11. Global Medical Radioactive Microspheres Sales Share by Manufacturers (2020-2025)

Table 12. Global Medical Radioactive Microspheres Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Medical Radioactive Microspheres Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Medical Radioactive Microspheres by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Medical Radioactive Microspheres as of 2024)

Table 16. Global Medical Radioactive Microspheres Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Medical Radioactive Microspheres Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)

Table 18. Key Manufacturers Medical Radioactive Microspheres Manufacturing Base and Headquarters

Table 19. Global Medical Radioactive Microspheres Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Medical Radioactive Microspheres Sales by Type (2020-2025) & (K Dose)

Table 23. Global Medical Radioactive Microspheres Sales by Type (2026-2031) & (K Dose)

Table 24. Global Medical Radioactive Microspheres Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Medical Radioactive Microspheres Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Medical Radioactive Microspheres ASP by Type (2020-2031) & (US$/Dose)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Medical Radioactive Microspheres Sales by Application (2020-2025) & (K Dose)

Table 29. Global Medical Radioactive Microspheres Sales by Application (2026-2031) & (K Dose)

Table 30. Medical Radioactive Microspheres High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Medical Radioactive Microspheres Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Medical Radioactive Microspheres Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Medical Radioactive Microspheres ASP by Application (2020-2031) & (US$/Dose)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Medical Radioactive Microspheres Growth Accelerators and Market Barriers

Table 37. North America Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Medical Radioactive Microspheres Sales (K Dose) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Medical Radioactive Microspheres Growth Accelerators and Market Barriers

Table 40. Europe Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Medical Radioactive Microspheres Sales (K Dose) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Medical Radioactive Microspheres Sales (K Dose) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Medical Radioactive Microspheres Growth Accelerators and Market Barriers

Table 45. Southeast Asia Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Medical Radioactive Microspheres Investment Opportunities and Key Challenges

Table 47. Central and South America Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Medical Radioactive Microspheres Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Medical Radioactive Microspheres Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. New Radiomedicine Technology Corporation Information

Table 51. New Radiomedicine Technology Description and Major Businesses

Table 52. New Radiomedicine Technology Product Models, Descriptions and Specifications

Table 53. New Radiomedicine Technology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 54. New Radiomedicine Technology Sales Value Proportion by Product in 2024

Table 55. New Radiomedicine Technology Sales Value Proportion by Application in 2024

Table 56. New Radiomedicine Technology Sales Value Proportion by Geographic Area in 2024

Table 57. New Radiomedicine Technology Medical Radioactive Microspheres SWOT Analysis

Table 58. New Radiomedicine Technology Recent Developments

Table 59. Grand Pharmaceutical Group Limited Corporation Information

Table 60. Grand Pharmaceutical Group Limited Description and Major Businesses

Table 61. Grand Pharmaceutical Group Limited Product Models, Descriptions and Specifications

Table 62. Grand Pharmaceutical Group Limited Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 63. Grand Pharmaceutical Group Limited Sales Value Proportion by Product in 2024

Table 64. Grand Pharmaceutical Group Limited Sales Value Proportion by Application in 2024

Table 65. Grand Pharmaceutical Group Limited Sales Value Proportion by Geographic Area in 2024

Table 66. Grand Pharmaceutical Group Limited Medical Radioactive Microspheres SWOT Analysis

Table 67. Grand Pharmaceutical Group Limited Recent Developments

Table 68. YH Nu-Med Corporation Information

Table 69. YH Nu-Med Description and Major Businesses

Table 70. YH Nu-Med Product Models, Descriptions and Specifications

Table 71. YH Nu-Med Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 72. YH Nu-Med Sales Value Proportion by Product in 2024

Table 73. YH Nu-Med Sales Value Proportion by Application in 2024

Table 74. YH Nu-Med Sales Value Proportion by Geographic Area in 2024

Table 75. YH Nu-Med Medical Radioactive Microspheres SWOT Analysis

Table 76. YH Nu-Med Recent Developments

Table 77. Boston Scientific Corporation Information

Table 78. Boston Scientific Description and Major Businesses

Table 79. Boston Scientific Product Models, Descriptions and Specifications

Table 80. Boston Scientific Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 81. Boston Scientific Sales Value Proportion by Product in 2024

Table 82. Boston Scientific Sales Value Proportion by Application in 2024

Table 83. Boston Scientific Sales Value Proportion by Geographic Area in 2024

Table 84. Boston Scientific Medical Radioactive Microspheres SWOT Analysis

Table 85. Boston Scientific Recent Developments

Table 86. Sirtex Medical Limited Corporation Information

Table 87. Sirtex Medical Limited Description and Major Businesses

Table 88. Sirtex Medical Limited Product Models, Descriptions and Specifications

Table 89. Sirtex Medical Limited Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 90. Sirtex Medical Limited Sales Value Proportion by Product in 2024

Table 91. Sirtex Medical Limited Sales Value Proportion by Application in 2024

Table 92. Sirtex Medical Limited Sales Value Proportion by Geographic Area in 2024

Table 93. Sirtex Medical Limited Medical Radioactive Microspheres SWOT Analysis

Table 94. Sirtex Medical Limited Recent Developments

Table 95. Terumo Corporation Information

Table 96. Terumo Description and Major Businesses

Table 97. Terumo Product Models, Descriptions and Specifications

Table 98. Terumo Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 99. Terumo Recent Developments

Table 100. ABK Biomedical Corporation Information

Table 101. ABK Biomedical Description and Major Businesses

Table 102. ABK Biomedical Product Models, Descriptions and Specifications

Table 103. ABK Biomedical Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 104. ABK Biomedical Recent Developments

Table 105. AtomVie Corporation Information

Table 106. AtomVie Description and Major Businesses

Table 107. AtomVie Product Models, Descriptions and Specifications

Table 108. AtomVie Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 109. AtomVie Recent Developments

Table 110. BWXT Medical Corporation Information

Table 111. BWXT Medical Description and Major Businesses

Table 112. BWXT Medical Product Models, Descriptions and Specifications

Table 113. BWXT Medical Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 114. BWXT Medical Recent Developments

Table 115. Key Raw Materials Distribution

Table 116. Raw Materials Key Suppliers

Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 118. Milestones in Production Technology Evolution

Table 119. Distributors List

Table 120. Market Trends and Market Evolution

Table 121. Market Drivers and Opportunities

Table 122. Market Challenges, Risks, and Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

List of Figures

Figure 1. Medical Radioactive Microspheres Product Picture

Figure 2. Global Medical Radioactive Microspheres Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Holmium-166 Microspheres Product Picture

Figure 4. Yttrium-90 Microspheres Product Picture

Figure 5. Global Medical Radioactive Microspheres Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 6. Cancer Treatment

Figure 7. Diagnosis

Figure 8. Others

Figure 9. Medical Radioactive Microspheres Report Years Considered

Figure 10. Global Medical Radioactive Microspheres Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 12. Global Medical Radioactive Microspheres Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Medical Radioactive Microspheres Revenue Market Share by Region (2020-2031)

Figure 14. Global Medical Radioactive Microspheres Sales (2020-2031) & (K Dose)

Figure 15. Global Medical Radioactive Microspheres Sales (CAGR) by Region (2020-2031) (K Dose)

Figure 16. Global Medical Radioactive Microspheres Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Medical Radioactive Microspheres Sales Volume Market Share in 2024

Figure 18. Global Medical Radioactive Microspheres Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Holmium-166 Microspheres Revenue Market Share by Manufacturer in 2024

Figure 21. Yttrium-90 Microspheres Revenue Market Share by Manufacturer in 2024

Figure 22. Global Medical Radioactive Microspheres Sales Market Share by Type (2020-2031)

Figure 23. Global Medical Radioactive Microspheres Revenue Market Share by Type (2020-2031)

Figure 24. Global Medical Radioactive Microspheres Sales Market Share by Application (2020-2031)

Figure 25. Global Medical Radioactive Microspheres Revenue Market Share by Application (2020-2031)

Figure 26. North America Medical Radioactive Microspheres Sales YoY (2020-2031) & (K Dose)

Figure 27. North America Medical Radioactive Microspheres Revenue YoY (2020-2031) & (US$ Million)

Figure 28. North America Top 5 Manufacturers Medical Radioactive Microspheres Sales Revenue (US$ Million) in 2024

Figure 29. North America Medical Radioactive Microspheres Sales Volume (K Dose) by Type (2020- 2031)

Figure 30. North America Medical Radioactive Microspheres Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 31. North America Medical Radioactive Microspheres Sales Volume (K Dose) by Application (2020-2031)

Figure 32. North America Medical Radioactive Microspheres Sales Revenue (US$ Million) by Application (2020-2031)

Figure 33. US Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 34. Canada Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 35. Mexico Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 36. Europe Medical Radioactive Microspheres Sales YoY (2020-2031) & (K Dose)

Figure 37. Europe Medical Radioactive Microspheres Revenue YoY (2020-2031) & (US$ Million)

Figure 38. Europe Top 5 Manufacturers Medical Radioactive Microspheres Sales Revenue (US$ Million) in 2024

Figure 39. Europe Medical Radioactive Microspheres Sales Volume (K Dose) by Type (2020-2031)

Figure 40. Europe Medical Radioactive Microspheres Sales Revenue (US$ Million) by Type (2020-2031)

Figure 41. Europe Medical Radioactive Microspheres Sales Volume (K Dose) by Application (2020-2031)

Figure 42. Europe Medical Radioactive Microspheres Sales Revenue (US$ Million) by Application (2020-2031)

Figure 43. Germany Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 44. France Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 45. U.K. Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 46. Italy Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 47. Russia Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 48. Asia-Pacific Medical Radioactive Microspheres Sales YoY (2020-2031) & (K Dose)

Figure 49. Asia-Pacific Medical Radioactive Microspheres Revenue YoY (2020-2031) & (US$ Million)

Figure 50. Asia-Pacific Top 8 Manufacturers Medical Radioactive Microspheres Sales Revenue (US$ Million) in 2024

Figure 51. Asia-Pacific Medical Radioactive Microspheres Sales Volume (K Dose) by Type (2020- 2031)

Figure 52. Asia-Pacific Medical Radioactive Microspheres Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 53. Asia-Pacific Medical Radioactive Microspheres Sales Volume (K Dose) by Application (2020-2031)

Figure 54. Asia-Pacific Medical Radioactive Microspheres Sales Revenue (US$ Million) by Application (2020-2031)

Figure 55. Indonesia Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 56. Japan Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 57. South Korea Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 58. China Taiwan Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 59. India Medical Radioactive Microspheres Revenue (2020-2031) & (US$ Million)

Figure 60. Central and South America Medical Radioactive Microspheres Sales YoY (2020-2031) & (K Dose)

Figure 61. Central and South America Medical Radioactive Microspheres Revenue YoY (2020-2031) & (US$ Million)

Figure 62. Central and South America Top 5 Manufacturers Medical Radioactive Microspheres Sales Revenue (US$ Million) in 2024

Figure 63. Central and South America Medical Radioactive Microspheres Sales Volume (K Dose) by Type (2021-2031)

Figure 64. Central and South America Medical Radioactive Microspheres Sales Revenue (US$ Million) by Type (2020-2031)

Figure 65. Central and South America Medical Radioactive Microspheres Sales Volume (K Dose) by Application (2020-2031)

Figure 66. Central and South America Medical Radioactive Microspheres Sales Revenue (US$ Million) by Application (2020-2031)

Figure 67. Brazil Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 68. Argentina Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 69. Middle East, and Africa Medical Radioactive Microspheres Sales YoY (2020-2031) & (K Dose)

Figure 70. Middle East and Africa Medical Radioactive Microspheres Revenue YoY (2020-2031) & (US$ Million)

Figure 71. Middle East and Africa Top 5 Manufacturers Medical Radioactive Microspheres Sales Revenue (US$ Million) in 2024

Figure 72. Middle East and Africa Medical Radioactive Microspheres Sales Volume (K Dose) by Type (2021-2031)

Figure 73. South America Medical Radioactive Microspheres Sales Revenue (US$ Million) by Type (2020-2031)

Figure 74. Middle East and Africa Medical Radioactive Microspheres Sales Volume (K Dose) by Application (2020-2031)

Figure 75. Middle East and Africa Medical Radioactive Microspheres Sales Revenue (US$ Million) by Application (2020-2031)

Figure 76. GCC Countries Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 77. Turkey Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 78. Egypt Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 79. South Africa Medical Radioactive Microspheres Revenue (2020-2025) & (US$ Million)

Figure 80. Medical Radioactive Microspheres Industry Chain Mapping

Figure 81. Regional Medical Radioactive Microspheres Manufacturing Base Distribution (%)

Figure 82. Global Medical Radioactive Microspheres Production Market Share by Region (2020-2031)

Figure 83. Medical Radioactive Microspheres Production Process

Figure 84. Regional Medical Radioactive Microspheres Production Cost Structure

Figure 85. Channels of Distribution (Direct Vs Distribution)

Figure 86. Bottom-up and Top-down Approaches for This Report

Figure 87. Data Triangulation

Figure 88. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions